Insmed was the top Nasdaq 100 gainer in early Monday trading, rising 8.4% intraday; year-to-date the stock is down about 15.3%. The article notes Thomson R as the worst-performing Nasdaq 100 component thus far on the day (entry appears truncated).
Insmed was the top Nasdaq 100 gainer in early Monday trading, rising 8.4% intraday; year-to-date the stock is down about 15.3%. The article notes Thomson R as the worst-performing Nasdaq 100 component thus far on the day (entry appears truncated).
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
neutral
Sentiment Score
0.00
Ticker Sentiment
